230 related articles for article (PubMed ID: 21860649)
1. Are Toll-like receptors and decoy receptors involved in the immunopathogenesis of systemic lupus erythematosus and lupus-like syndromes?
Guggino G; Giardina AR; Ciccia F; Triolo G; Dieli F; Sireci G
Clin Dev Immunol; 2012; 2012():135932. PubMed ID: 21860649
[TBL] [Abstract][Full Text] [Related]
2. Breakdown of Immune Tolerance in Systemic Lupus Erythematosus by Dendritic Cells.
Liao X; Reihl AM; Luo XM
J Immunol Res; 2016; 2016():6269157. PubMed ID: 27034965
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies targeting TLR and SMAD pathways define new subgroups in systemic lupus erythematosus.
Lewis MJ; McAndrew MB; Wheeler C; Workman N; Agashe P; Koopmann J; Uddin E; Morris DL; Zou L; Stark R; Anson J; Cope AP; Vyse TJ
J Autoimmun; 2018 Jul; 91():1-12. PubMed ID: 29576246
[TBL] [Abstract][Full Text] [Related]
4. Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus.
Wong CK; Wong PT; Tam LS; Li EK; Chen DP; Lam CW
Clin Exp Immunol; 2010 Jan; 159(1):11-22. PubMed ID: 19843090
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor signalling in B cells during systemic lupus erythematosus.
Fillatreau S; Manfroi B; Dörner T
Nat Rev Rheumatol; 2021 Feb; 17(2):98-108. PubMed ID: 33339987
[TBL] [Abstract][Full Text] [Related]
6. A Toll for lupus.
Anders HJ
Lupus; 2005; 14(6):417-22. PubMed ID: 16038103
[TBL] [Abstract][Full Text] [Related]
7. Single-cell systems-level analysis of human Toll-like receptor activation defines a chemokine signature in patients with systemic lupus erythematosus.
O'Gorman WE; Hsieh EW; Savig ES; Gherardini PF; Hernandez JD; Hansmann L; Balboni IM; Utz PJ; Bendall SC; Fantl WJ; Lewis DB; Nolan GP; Davis MM
J Allergy Clin Immunol; 2015 Nov; 136(5):1326-36. PubMed ID: 26037552
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptors pathways implication in common autoimmune diseases and therapeutic perspectives.
Alexoudi I; Kapsimali V; Vaiopoulos A; Kanakis M; Vaiopoulos G
G Ital Dermatol Venereol; 2015 Apr; 150(2):255-60. PubMed ID: 25876147
[TBL] [Abstract][Full Text] [Related]
9. Neutrophils, Dendritic Cells, Toll-Like Receptors, and Interferon-α in Lupus Nephritis.
Lorenz G; Anders HJ
Semin Nephrol; 2015 Sep; 35(5):410-26. PubMed ID: 26573544
[TBL] [Abstract][Full Text] [Related]
10. Role of Toll like receptor-activated dendritic cells in the development of autoimmunity.
Granucci F; Zanoni I
Front Biosci; 2008 May; 13():4817-26. PubMed ID: 18508547
[TBL] [Abstract][Full Text] [Related]
11. Role for toll-like receptors in autoimmune disease: the example of systemic lupus erythematosus.
Richez C; Blanco P; Rifkin I; Moreau JF; Schaeverbeke T
Joint Bone Spine; 2011 Mar; 78(2):124-30. PubMed ID: 20961794
[TBL] [Abstract][Full Text] [Related]
12. Roles of B Cell-Intrinsic TLR Signals in Systemic Lupus Erythematosus.
Ma K; Li J; Fang Y; Lu L
Int J Mol Sci; 2015 Jun; 16(6):13084-105. PubMed ID: 26068236
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 7-stimulated tumor necrosis factor α causes bone marrow damage in systemic lupus erythematosus.
Zhuang H; Han S; Xu Y; Li Y; Wang H; Yang LJ; Reeves WH
Arthritis Rheumatol; 2014 Jan; 66(1):140-51. PubMed ID: 24449581
[TBL] [Abstract][Full Text] [Related]
14. Development of TLR inhibitors for the treatment of autoimmune diseases.
Barrat FJ; Coffman RL
Immunol Rev; 2008 Jun; 223():271-83. PubMed ID: 18613842
[TBL] [Abstract][Full Text] [Related]
15. Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus.
Thibault DL; Graham KL; Lee LY; Balboni I; Hertzog PJ; Utz PJ
Arthritis Res Ther; 2009; 11(4):R112. PubMed ID: 19624844
[TBL] [Abstract][Full Text] [Related]
16. TLRs and IFNs: critical pieces of the autoimmunity puzzle.
Theofilopoulos AN
J Clin Invest; 2012 Oct; 122(10):3464-6. PubMed ID: 23154274
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T cells and systemic lupus erythematosus.
Mudd PA; Teague BN; Farris AD
Scand J Immunol; 2006 Sep; 64(3):211-8. PubMed ID: 16918689
[TBL] [Abstract][Full Text] [Related]
18. Pyruvate Kinase M2 Contributes to TLR-Mediated Inflammation and Autoimmunity by Promoting Pyk2 Activation.
Zhang X; Yang Y; Jing L; Zhai W; Zhang H; Ma Q; Li C; Yan F; Cheng D; Zhang J; Ning Z; Shi H; Wang C; Zhao M; Dai J; Li Z; Ming J; Yu M; Wang H; Cheng H; Xiong H; Dong G
Front Immunol; 2021; 12():680068. PubMed ID: 34025679
[TBL] [Abstract][Full Text] [Related]
19. Role of the innate and adaptive immune responses in the pathogenesis of systemic lupus erythematosus.
Bolouri N; Akhtari M; Farhadi E; Mansouri R; Faezi ST; Jamshidi A; Mahmoudi M
Inflamm Res; 2022 Jun; 71(5-6):537-554. PubMed ID: 35298669
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptors: potential targets for lupus treatment.
Wu YW; Tang W; Zuo JP
Acta Pharmacol Sin; 2015 Dec; 36(12):1395-407. PubMed ID: 26592511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
